Oruka Therapeutics, Inc. (ORKA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$9.18M2011: -$7.36M2012: -$4.32M2013: -$6.94M2014: -$9.69M2015: -$11.46M2016: -$16.61M2017: -$18.71M2018: -$8.12M2019: -$5.81M2020: -$9.77M2021: -$19.34M2022: -$10.60M2023: -$7.30M2025: -$122.05M-$122.05M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$122.05M
2023-$7.30M+31.1%
2022-$10.60M+45.2%
2021-$19.34M-98.0%
2020-$9.77M-68.0%
2019-$5.81M+28.4%
2018-$8.12M+56.6%
2017-$18.71M-12.6%
2016-$16.61M-45.0%
2015-$11.46M-18.2%
2014-$9.69M-39.7%
2013-$6.94M-60.7%
2012-$4.32M+41.3%
2011-$7.36M+19.8%
2010-$9.18M